Press Release | NeoGenomics Laboratories

August 22, 2014

NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option

August 15, 2014

NeoGenomics Announces Pricing of $32.2 Million Public Offering

August 14, 2014

NeoGenomics Announces Public Offering of Common Stock

July 17, 2014

NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014

July 11, 2014

NeoGenomics Expands Next Generation Sequencing Services and Offers 23 Different Profiles for Various Hematologic and Solid Cancers

July 8, 2014

NeoGenomics Completes Acquisition of Path Logic

June 23, 2014

NeoGenomics Raises Guidance and Projects 30% Year-Over-Year Revenue Growth in Quarter 2, 2014

June 18, 2014

NeoGenomics Schedules its Q2 2014 Earnings Release for July 17, 2014

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients